Investors
Our investor proposition
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical, vaccine and consumer healthcare products.
Key information
2020 First quarter results announcement
We announced our first quarter results for the period ended 31 March 2020 on Wednesday 29 April.
Latest information
Latest press releases
- GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio
- GSK highlights scientific innovation and advances in its growing oncology portfolio at ASCO 2020
- Global HIV prevention study to stop early after ViiV Healthcare’s long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral PrEP
Annual Report 2019
We published our Annual Report 2019 on 04 March 2020. View the summary and download the full report or individual sections.